A commercial porcine circovirus (PCV) type 2a-based vaccine reduces PCV2d viremia and shedding and prevents PCV2d transmission to naïve pigs under experimental conditions. (2017)
Attributed to:
Host responses underlying immunity
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.vaccine.2016.11.085
PubMed Identifier: 27919634
Publication URI: http://europepmc.org/abstract/MED/27919634
Type: Journal Article/Review
Volume: 35
Parent Publication: Vaccine
Issue: 2
ISSN: 0264-410X